ZSAN - Zosano Pharma GAAP EPS of -$0.06 misses by $0.02 revenue of $0.09M misses by $1.39M
Zosano Pharma press release (NASDAQ:ZSAN): Q4 GAAP EPS of -$0.06 misses by $0.02. Revenue of $0.09M (-59.1% Y/Y) misses by $1.39M. Shares -3.82% AH. As of December 31, 2021, cash and cash equivalents were $11.0 million, compared with $35.3 million as of December 31, 2020.
For further details see:
Zosano Pharma GAAP EPS of -$0.06 misses by $0.02, revenue of $0.09M misses by $1.39M